Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) EGFR Mutation Test Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global EGFR Mutation Test Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 DNA Sequencing
      • 1.3.3 Kits
    • 1.4 Market Segment by Application
      • 1.4.1 Global EGFR Mutation Test Market Share by Application (2019-2025)
      • 1.4.2 Cancer Hospitals
      • 1.4.3 Clinical Research Institutes
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global EGFR Mutation Test Production Value 2014-2025
      • 2.1.2 Global EGFR Mutation Test Production 2014-2025
      • 2.1.3 Global EGFR Mutation Test Capacity 2014-2025
      • 2.1.4 Global EGFR Mutation Test Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global EGFR Mutation Test Market Size CAGR of Key Regions
      • 2.2.2 Global EGFR Mutation Test Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global EGFR Mutation Test Capacity by Manufacturers
      • 3.1.2 Global EGFR Mutation Test Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 EGFR Mutation Test Revenue by Manufacturers (2014-2019)
      • 3.2.2 EGFR Mutation Test Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)
    • 3.3 EGFR Mutation Test Price by Manufacturers
    • 3.4 Key Manufacturers EGFR Mutation Test Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into EGFR Mutation Test Market
    • 3.6 Key Manufacturers EGFR Mutation Test Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 DNA Sequencing Production and Production Value (2014-2019)
      • 4.1.2 Kits Production and Production Value (2014-2019)
    • 4.2 Global EGFR Mutation Test Production Market Share by Type
    • 4.3 Global EGFR Mutation Test Production Value Market Share by Type
    • 4.4 EGFR Mutation Test Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global EGFR Mutation Test Consumption by Application

    6 Production by Regions

    • 6.1 Global EGFR Mutation Test Production (History Data) by Regions 2014-2019
    • 6.2 Global EGFR Mutation Test Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States EGFR Mutation Test Production Growth Rate 2014-2019
      • 6.3.2 United States EGFR Mutation Test Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States EGFR Mutation Test Import & Export
    • 6.4 European Union
      • 6.4.1 European Union EGFR Mutation Test Production Growth Rate 2014-2019
      • 6.4.2 European Union EGFR Mutation Test Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union EGFR Mutation Test Import & Export
    • 6.5 China
      • 6.5.1 China EGFR Mutation Test Production Growth Rate 2014-2019
      • 6.5.2 China EGFR Mutation Test Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China EGFR Mutation Test Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 EGFR Mutation Test Consumption by Regions

    • 7.1 Global EGFR Mutation Test Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States EGFR Mutation Test Consumption by Type
      • 7.2.2 United States EGFR Mutation Test Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union EGFR Mutation Test Consumption by Type
      • 7.3.2 European Union EGFR Mutation Test Consumption by Application
    • 7.4 China
      • 7.4.1 China EGFR Mutation Test Consumption by Type
      • 7.4.2 China EGFR Mutation Test Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World EGFR Mutation Test Consumption by Type
      • 7.5.2 Rest of World EGFR Mutation Test Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Abbott
      • 8.1.1 Abbott Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of EGFR Mutation Test
      • 8.1.4 EGFR Mutation Test Product Introduction
      • 8.1.5 Abbott Recent Development
    • 8.2 Merck
      • 8.2.1 Merck Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of EGFR Mutation Test
      • 8.2.4 EGFR Mutation Test Product Introduction
      • 8.2.5 Merck Recent Development
    • 8.3 Thermo Fisher Scientific
      • 8.3.1 Thermo Fisher Scientific Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of EGFR Mutation Test
      • 8.3.4 EGFR Mutation Test Product Introduction
      • 8.3.5 Thermo Fisher Scientific Recent Development
    • 8.4 Illumina
      • 8.4.1 Illumina Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of EGFR Mutation Test
      • 8.4.4 EGFR Mutation Test Product Introduction
      • 8.4.5 Illumina Recent Development
    • 8.5 BioMerieux
      • 8.5.1 BioMerieux Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of EGFR Mutation Test
      • 8.5.4 EGFR Mutation Test Product Introduction
      • 8.5.5 BioMerieux Recent Development
    • 8.6 QIAGEN
      • 8.6.1 QIAGEN Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of EGFR Mutation Test
      • 8.6.4 EGFR Mutation Test Product Introduction
      • 8.6.5 QIAGEN Recent Development
    • 8.7 Agilent Technologies
      • 8.7.1 Agilent Technologies Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of EGFR Mutation Test
      • 8.7.4 EGFR Mutation Test Product Introduction
      • 8.7.5 Agilent Technologies Recent Development
    • 8.8 Hologic
      • 8.8.1 Hologic Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of EGFR Mutation Test
      • 8.8.4 EGFR Mutation Test Product Introduction
      • 8.8.5 Hologic Recent Development
    • 8.9 Novartis
      • 8.9.1 Novartis Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of EGFR Mutation Test
      • 8.9.4 EGFR Mutation Test Product Introduction
      • 8.9.5 Novartis Recent Development
    • 8.10 Roche
      • 8.10.1 Roche Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of EGFR Mutation Test
      • 8.10.4 EGFR Mutation Test Product Introduction
      • 8.10.5 Roche Recent Development
    • 8.11 Genomic Health

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global EGFR Mutation Test Capacity, Production Forecast 2019-2025
      • 9.1.2 Global EGFR Mutation Test Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global EGFR Mutation Test Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global EGFR Mutation Test Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global EGFR Mutation Test Production Forecast by Type
      • 9.7.2 Global EGFR Mutation Test Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 EGFR Mutation Test Sales Channels
      • 10.2.2 EGFR Mutation Test Distributors
    • 10.3 EGFR Mutation Test Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.   
      Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
      In 2019, the market size of EGFR Mutation Test is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for EGFR Mutation Test.

      This report studies the global market size of EGFR Mutation Test, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the EGFR Mutation Test production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott
      Merck
      Thermo Fisher Scientific
      Illumina
      BioMerieux
      QIAGEN
      Agilent Technologies
      Hologic
      Novartis
      Roche
      Genomic Health

      Market Segment by Product Type
      DNA Sequencing
      Kits

      Market Segment by Application
      Cancer Hospitals
      Clinical Research Institutes

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the EGFR Mutation Test status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key EGFR Mutation Test manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of EGFR Mutation Test are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now